Effectiveness of NELSON versus PLCOm2012 lung cancer screening eligibility criteria in Germany (HANSE): a prospective cohort study

Authors

Institutions

Publication Details

Journal
The Lancet Oncology
Published
2025-11-11
DOI
https://doi.org/10.1016/s1470-2045(25)00490-5
Citations
1
Primary Topic
Lung Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of NELSON versus PLCOm2012 lung cancer screening eligibility criteria in Germany (HANSE): a prospective cohort study

Rudolf Kaaks, Katharina May, Susanne Stiebeler, Martin Reck et al.
1 citations
The Lancet Oncology
Lung Cancer Diagnosis and Treatment
1.52
article

Effectiveness of NELSON versus PLCOm2012 lung cancer screening eligibility criteria in Germany (HANSE): a prospective cohort study

Rudolf Kaaks, Katharina May, Susanne Stiebeler, Martin Reck, Jörg Barkhausen, Alexander Kuhlmann, Gerald Schmid‐Bindert, Benjamin‐Alexander Bollmann, Anton Faron, Sabine Dettmer, Jens Vogel‐Claussen, Sabine Bohnet
article en
1 citations

Abstract

No abstract available for this paper.
The Lancet OncologyVol. 26(12)
Heidelberg University (DE), University Hospital Heidelberg (DE), University Medical Centre Mannheim (DE)
Openalex Percentile: Top 13%
Lung Cancer Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.